期刊文献+

天然溶瘤新城疫病毒Italien株HN基因真核表达载体的构建和表达 被引量:1

Construction of eukaryotic vector for HN gene of NDV Italien strain and its expression
在线阅读 下载PDF
导出
摘要 目的构建天然溶瘤型新城疫病毒(NDV)Italien株血凝素-神经氨酸酶(HN)基因的真核表达载体并进行产物表达。方法采用RT-PCR法从病毒RNA中克隆HNcDNA,并构建HN的真核表达载体pcDNA3.1-HN,脂质体法转染CHO-K1,G418筛选稳定表达克隆。用Westernblot、免疫荧光法检测HN蛋白的表达。结果经限制性酶切鉴定及DNA测序分析,证实真核表达载体pcDNA3.1-HN构建正确。Westernblot和免疫荧光分析表明HN基因在CHO-K1中成功表达。结论天然溶瘤型NDVItalien株的HNcDNA被成功克隆,所构建的真核表达载体pcDNA3.1-HN可以在CHO-K1细胞中稳定表达。 Objective To construct an eukaryotic expression plasmid containing gene coding for the hemagglutinin-neurarninidase (HN) of newcastle disease virus (NDV) oncolytic strain Italien, and then to express the protein in eukaryotic cell. Method The HN cDNA was synthesized from viral RNA by RT-PCR, and the eukaryotic expression vector of HN gene (named pcDNA3. 1-HN) was constructed. The vector pcDNA3. 1-HN was transfected into CHO-K1 cell by liposome, and G418 was used to select stable clones expressing HN gene. The expression of HN protein was visualized by Western blot and Immunofluorescence microscopy. Results Restriction analysis and DNA sequencing proved that HN gene was correctly cloned into expression vector. Western blot analysis and immunofluorescence showed that the HN was expressed in CHO-K1 cells. Conclusion The HN cDNA of NDV was successfully cloned into eukaryotic vector which showed good expression of HN protein in CHO-K1 cells.
出处 《解放军医学杂志》 CAS CSCD 北大核心 2007年第2期100-103,共4页 Medical Journal of Chinese People's Liberation Army
基金 国家自然科学基金资助项目(30671196) 全军医药卫生科研项目(06MA218)
关键词 新城疫病毒 血凝素-神经氨酸酶基因 转染 基因表达 newcastle disease virus hemagglutinin-neuraminidase gene transfection gene expression
  • 相关文献

参考文献10

  • 1Parato KA,Senger D,Forsyth PA,et al.Recent progress in the battle between oncolytic viruses and tumours.Nat Rev Cancer,2005,5(12):965
  • 2Sinkovics JG,Horvath JC.Newcastle disease virus (NDV):brief history of its oncolytic strains.J Clin Virol,2000,16(1):1
  • 3边惠洁,陈志南.负链RNA病毒与肿瘤基因/病毒治疗//樊代明.肿瘤研究前沿.西安:西安交通大学出版社,2004.115-122
  • 4Li J,Quinlan E,Mirza A,et al.Mutated form of the Newcastle disease virus hemagglutinin-neuraminidase interacts with the homologous fusion protein despite deficiencies in both receptor recognition and fusion promotion.J Virol,2004,78(10):5299
  • 5Lorence RM,Pecora AL,Major PP,et al.Overview of phase I studies of intravenous administration of PV701,an oncolytic virus.Curr Opin Mol Ther,2003,5(6):618
  • 6Csatary LK,Gosztonyi G,Szeberenyi J,et al.MTH-68/H oncolytic viral treatment in human high-grade gliomas.J Neurooncol,2004,67(1-2):83
  • 7Fiola C,Peeters B,Fournier P,et al.Tumor selective replication of Newcastle disease virus:Association with defects of tumor cells in antiviral defence.Int J Cancer,2006,119(2):328
  • 8Bian H,Fournier P,Moormann R,et al.Selective gene transfer in vitro to tumor cells via recombinant Newcastle disease virus.Cancer Gene Ther,2005,12(3):295
  • 9Bian H,Fournier P,Moormann R,et al.Selective gene transfer to tumor cells by recombinant Newcastle disease virus via a bispecific fusion protein.Int J Oncol,2005,26(2):431
  • 10Bian H,Fournier P,Peeters B,et al.Tumor-targeted gene transfer in vivo via recombinant Newcastle disease virus modified by a bispecific fusion protein.Int J Oncol,2005,27(2):377

同被引文献12

  • 1Knipe DM, Howley PM. Fields Virology[D]. 5th ed. Philadelphia: Lippincott Willliams & Wilkins, 2007. 1451-1498.
  • 2Schirrmacher V, Fournier P. Newcastle disease virus: a promising vector for viral therapy, immune therapy, and gene therapy of cancer[J]. Methods Mol Biol, 2009, 542: 565-605.
  • 3Bian H, Fournier P, Moormann R, et al. Selective gene transfer in vitro to tumor cells via recombinant Newcastle disease virus[J]. Cancer Gene Ther, 2005, 12(3): 295-303.
  • 4Feng H, Wei Dj Nan G, et al. Construction of a minigenome rescue system for Newcastle disease virus strain Italien[J]. Arch Virol, 2011, 156(4): 611-616.
  • 5Wei D, Yang B, Li YL, et al. Characterization of the genome sequence of an oncolytic Newcastle disease virus strain Italien[J]. Virus Res, 2008, 135(2): 312-319.
  • 6Ogino T, Kobayashi M, Iwama M, et al. Sendal virus RNA- dependent RNA polymerase L protein catalyzes cap methylation of virus-specific mRNA[J]. J Biol Chem, 2005, 280(6): 4429- 4435.
  • 7Hercyk N, Horikami SM, Moyer SA. The vesicular stomatitis virus L protein possesses the mRNA methyltransferase activities [J]. Virology, 1988, 163 (1): 222-225.
  • 8Grdzelishvili V Z, Smallwood S, Tower D, et al. A single amino acid change in the L-polymerase protein of vesicular stomatitis virus completely abolishes viral mRNA cap methylation[J]. J Virol, 2005, 79 (12): 7327-7337.
  • 9Peeters BP, de Leeuw OS, Koch G, et al. Rescue of Newcastle disease virus from cloned cDNA: evidence that cleavability of the fusion protein is a major determinant for virulence[J]. J Virol, 1999, 73(6): 5001-5009.
  • 10Buchholz UJ, Finke S, Conzelmann KK. Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter[J].J Virol, 1999, 73(1): 251-2$9.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部